Oncology On The Go

S1 Ep82: Experts Discuss Differences in Radiotherapy Outcomes in BRCA+ Breast Cancer


Listen Later

During Breast Cancer Awareness Month 2023,  Rebecca M. Shulman, MD, an assistant professor in the Department of Radiation Oncology at Fox Chase Cancer Center, and Zachary Kiss, DO, a third-year resident physician in radiation oncology at Fox Chase, spoke about findings from their study, which assessed how BRCA1/2 mutations in patients with breast cancer do not appear to affect treatment outcomes with radiotherapy. 


Shulman and Kiss presented these findings as part of a poster session at the 2023 American Society for Radiation Oncology (ASTRO) Annual Meeting.


Disease-free survival (DFS) outcomes following radiation were reported to be comparable between patients with no BRCA mutations (n = 1482) and those with BRCA-mutated disease (n = 77; P = .26). Additionally, those with BRCA1/2 mutations tended to be younger (P = .004), have higher clinical stage disease (P <.006), and were more likely to undergo mastectomy (P <.001) than patients without mutated disease.


An analysis of patients with BRCA-mutated disease also indicated that those with BRCA1 mutations (n = 31) tended to be younger than those with BRCA2 mutations (n = 46; P = .006). Moreover, a higher proportion of patients with BRCA1 mutations had estrogen receptor– or progesterone receptor–negative disease (P <.001) and higher T stage (P = .032).


Shulman and Kiss also spoke about how next steps for research may include investigating potential additional mutations and other factors that may affect sensitivity to radiotherapy among patients with disease harboring BRCA mutations. They also discussed other presentations at this year’s ASTRO meeting that may support advancement towards individualized treatment approaches in patients with breast cancer. 


“Investigating the genetic and biochemical basis of cancer is a monumental task, requiring patients, ingenuity, and a continuing investment of time and resources,” Shulman said. “It’s important to communicate that progress in cancer treatment has been enormous, but that it is also incremental by nature and will require the efforts of many researchers pursuing many different ideas.”

...more
View all episodesView all episodes
Download on the App Store

Oncology On The GoBy CancerNetwork

  • 3.5
  • 3.5
  • 3.5
  • 3.5
  • 3.5

3.5

4 ratings


More shows like Oncology On The Go

View all
Journal of Clinical Oncology (JCO) Podcast by American Society of Clinical Oncology (ASCO)

Journal of Clinical Oncology (JCO) Podcast

39 Listeners

JAMA Clinical Reviews by JAMA Network

JAMA Clinical Reviews

500 Listeners

ASCO Daily News by American Society of Clinical Oncology (ASCO)

ASCO Daily News

57 Listeners

The Daily by The New York Times

The Daily

112,384 Listeners

OncoPharm by John Bossaer

OncoPharm

184 Listeners

The Intelligence from The Economist by The Economist

The Intelligence from The Economist

2,531 Listeners

The Uromigos by The Uromigos

The Uromigos

56 Listeners

The Oncology Podcast by The Oncology Network

The Oncology Podcast

4 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

33 Listeners

Huberman Lab by Scicomm Media

Huberman Lab

29,195 Listeners

The Ezra Klein Show by New York Times Opinion

The Ezra Klein Show

16,203 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler &amp; more

Biotech Hangout

20 Listeners

The Weekly Show with Jon Stewart by Comedy Central

The Weekly Show with Jon Stewart

10,858 Listeners

Two Onc Docs by Sam and Karine

Two Onc Docs

185 Listeners

Oncology Brothers: Practice-Changing Cancer Discussions by Oncology Brothers

Oncology Brothers: Practice-Changing Cancer Discussions

43 Listeners